Wednesday, October 19, 2022
6:00 PM – 8:00 PM EDT
Virtual Symposium live at: 6:00 PM Eastern; 5:00 PM Central; 4:00 PM Mountain; 3:00 PM Pacific
FACULTY
 |
Michael R. Grunwald, MD Chief, Leukemia Division Director, Transplantation and Cellular Therapy Program Levine Cancer Institute, Atrium Health Charlotte, NC |
 |
Ryan Jacobs, MD Principle Investigator of CLL Clinical Trials Department of Hematology, Lymphoma Division Assistant Professor of Medicine Levine Cancer Institute, Atrium Health Charlotte, NC |
LEARNING OBJECTIVES
Upon the completion of this program, attendees should be able to:
- Summarize the relevance of molecular markers and genetic data relevant to selection of therapy in CLL or AML
- Review relevant treatment best practices in both newly diagnosed and relapsed/refractory AML in consideration of disease- and patient-specific factors to inform shared decision-making
- Evaluate potential adverse events associated CLL and AML therapies to implement appropriate monitoring and counseling
TARGET AUDIENCE
This virtually live activity is intended for US-based hematologists, medical oncologists, and other healthcare providers involved in the management of patients with CLL and/or AML.
ACCREDITATION STATEMENT
Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. This CME activity was planned and produced in accordance with the ACCME Essentials.
CREDIT DESIGNATION STATEMENT
Med Learning Group designates this virtually live activity for a maximum of 2.0 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the virtually live activity.
NURSING CREDIT INFORMATION
Purpose: This program would be beneficial for nurses involved in the care of patients with CLL and/or AML.
CNE Credits: 2.0 ANCC Contact Hours
CNE ACCREDITATION STATEMENT
Ultimate Medical Academy/Complete Conference Management (CCM) is accredited as a provider of nursing continuing professional education development by the American Nurses Credentialing Center’s Commission on Accreditation.
Awarded 2.0 contact hour(s) of continuing nursing education of RNs and APNs.
DISCLAIMER
Med Learning Group makes every effort to develop CME activities that are scientifically based. This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.
For CME questions, please contact Med Learning Group at [email protected]
Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement information at www.medlearninggroup.com/privacy-policy/
AMERICANS WITH DISABILITY ACT
Staff will be glad to assist you with any special needs. Please contact Med Learning Group prior to participating at [email protected]
